934 related articles for article (PubMed ID: 16185577)
1. CagA status and Helicobacter pylori eradication among dyspeptic patients.
Magalhães AF; Carvalhaes A; Natan-Eisig J; Paraíso-Ferraz JG; Trevisan M; Zaterkaad S
Gastroenterol Hepatol; 2005 Oct; 28(8):441-4. PubMed ID: 16185577
[TBL] [Abstract][Full Text] [Related]
2. Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy.
Lindsetmo RO; Johnsen R; Revhaug A
Scand J Gastroenterol; 1998 Mar; 33(3):231-5. PubMed ID: 9548613
[TBL] [Abstract][Full Text] [Related]
3. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
4. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
5. Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Tankovic J; Lamarque D; Lascols C; Soussy CJ; Delchier JC
Pathol Biol (Paris); 2001 Sep; 49(7):528-33. PubMed ID: 11642014
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Sugiyama T; Kato M; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S
Helicobacter; 2001 Sep; 6(3):254-61. PubMed ID: 11683930
[TBL] [Abstract][Full Text] [Related]
8. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
9. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.
Pilotto A; Franceschi M; Leandro G; Bozzola L; Fortunato A; Rassu M; Meli S; Soffiati G; Scagnelli M; Di Mario F; Valerio G
J Gastroenterol Hepatol; 1999 May; 14(5):468-75. PubMed ID: 10355512
[TBL] [Abstract][Full Text] [Related]
11. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure.
De Francesco V; Zullo A; Margiotta M; Marangi S; Burattini O; Berloco P; Russo F; Barone M; Di Leo A; Minenna MF; Stoppino V; Morini S; Panella C; Francavilla A; Ierardi E
Aliment Pharmacol Ther; 2004 Feb; 19(4):407-14. PubMed ID: 14871280
[TBL] [Abstract][Full Text] [Related]
12. Failure of Helicobacter pylori eradication: is poor compliance the main cause?
Wermeille J; Cunningham M; Dederding JP; Girard L; Baumann R; Zelger G; Buri P; Metry JM; Sitavanc R; Gallaz L; Merki H; Godin N
Gastroenterol Clin Biol; 2002 Mar; 26(3):216-9. PubMed ID: 11981460
[TBL] [Abstract][Full Text] [Related]
13. Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
Lamouliatte H; Samoyeau R; De Mascarel A; Megraud F
Aliment Pharmacol Ther; 1999 Nov; 13(11):1523-30. PubMed ID: 10571611
[TBL] [Abstract][Full Text] [Related]
14. Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori.
Sieg A; Sellinger M; Schlauch D; Hörner M; Fuchs W
Aliment Pharmacol Ther; 1999 Jul; 13(7):865-8. PubMed ID: 10383519
[TBL] [Abstract][Full Text] [Related]
15. A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection.
Shashidhar H; Peters J; Lin CH; Rabah R; Thomas R; Tolia V
J Pediatr Gastroenterol Nutr; 2000 Mar; 30(3):276-82. PubMed ID: 10749411
[TBL] [Abstract][Full Text] [Related]
16. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
17. Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia.
Tan HJ; Rizal AM; Rosmadi MY; Goh KL
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):110-5. PubMed ID: 16706821
[TBL] [Abstract][Full Text] [Related]
18. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children.
Kato S; Ritsuno H; Ohnuma K; Iinuma K; Sugiyama T; Asaka M
Helicobacter; 1998 Dec; 3(4):278-82. PubMed ID: 9844069
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U
Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
